Scanogen is a molecular diagnostic company developing systems to read the biomolecular information of body fluids with the goal of improving health care. The Company has developed Single MOLecule Tethering (SMOLT), a proprietary technology for rapid and ultra-sensitive detection of biomolecules. The Company is using this technology to develop a simple-to-use and sample-to-answer diagnostic platform. Scanogen has received NIH grants totaling $9.5 million to develop its diagnostic assays and it is currently focused on two areas: Point-of-care diagnosis and bloodstream infection detection.
Looking for a particular Scanogen Inc. employee's phone or email?
The Scanogen Inc. annual revenue was $1 million in 2026.
Alfredo Celedon is the Founder and CEO of Scanogen Inc..
20 people are employed at Scanogen Inc..
Scanogen Inc. is based in Baltimore, Maryland.
The NAICS codes for Scanogen Inc. are [541714, 5417, 541, 54, 54171].
The SIC codes for Scanogen Inc. are [87, 873].